 | • レポートコード：D0GIR-00894 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がんゲノム検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。がんゲノム検査の種類別市場規模（乳がんゲノム検査、肺がんゲノム検査、血液がんゲノム検査、肝がんゲノム検査、胃がんゲノム検査、その他）、用途別市場規模（病院、クリニック、診断研究所、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Myriad Genetics、Positive Bioscience、Quest Diagnostics、Centogene AG、LabCorp、Color Genomics、Illumina, Inc.、Gene By Gene Ltd.、23andMe Inc.、Bio-Rad Laboratories、Agilent Technologies、Thermo Fisher Scientific ・地域別グローバル市場分析 2015年-2020年 ・がんゲノム検査の北米市場（アメリカ、カナダ、メキシコ） ・がんゲノム検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がんゲノム検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がんゲノム検査の南米市場（ブラジル、アルゼンチン） ・がんゲノム検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：乳がんゲノム検査、肺がんゲノム検査、血液がんゲノム検査、肝がんゲノム検査、胃がんゲノム検査、その他 ・用途別分析：病院、クリニック、診断研究所、学術・研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Cancer Genomic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cancer Genomic Testing sales will be xx in 2020 from Cancer Genomic Testing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cancer Genomic Testing market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cancer Genomic Testing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cancer Genomic Testing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cancer Genomic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Genomic Testing market has been segmented into:
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
By Application, Cancer Genomic Testing has been segmented into:
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Genomic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Genomic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Genomic Testing market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Genomic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Genomic Testing Market Share Analysis
Cancer Genomic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Genomic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Genomic Testing sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Genomic Testing are:
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Centogene AG
LabCorp
Color Genomics
Illumina, Inc.
Gene By Gene Ltd.
23andMe Inc.
Bio-Rad Laboratories
Agilent Technologies
Thermo Fisher Scientific
Among other players domestic and global, Cancer Genomic Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Cancer Genomic Testing Market Overview
1.1 Product Overview and Scope of Cancer Genomic Testing
1.2 Classification of Cancer Genomic Testing by Type
1.2.1 Global Cancer Genomic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Genomic Testing Revenue Market Share by Type in 2019
1.2.3 Breast Cancer Genomic Testing
1.2.4 Lung Cancer Genomic Testing
1.2.5 Blood Cancer Genomic Testing
1.2.6 Liver Cancer Genomic Testing
1.2.7 Stomach Cancer Genomic Testing
1.2.8 Others
1.3 Global Cancer Genomic Testing Market by End Users
1.3.1 Overview: Global Cancer Genomic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Global Cancer Genomic Testing Market by Regions
1.4.1 Global Cancer Genomic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Genomic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Genomic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Genomic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Genomic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Genomic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Genomic Testing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Cancer Genomic Testing Industry Impact
1.5.1 COVID-19 Potential Implications for the Cancer Genomic Testing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cancer Genomic Testing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Myriad Genetics
2.1.1 Myriad Genetics Details
2.1.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Myriad Genetics SWOT Analysis
2.1.4 Myriad Genetics Product and Services
2.1.5 Myriad Genetics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Positive Bioscience
2.2.1 Positive Bioscience Details
2.2.2 Positive Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Positive Bioscience SWOT Analysis
2.2.4 Positive Bioscience Product and Services
2.2.5 Positive Bioscience Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Quest Diagnostics SWOT Analysis
2.3.4 Quest Diagnostics Product and Services
2.3.5 Quest Diagnostics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Centogene AG
2.4.1 Centogene AG Details
2.4.2 Centogene AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Centogene AG SWOT Analysis
2.4.4 Centogene AG Product and Services
2.4.5 Centogene AG Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 LabCorp
2.5.1 LabCorp Details
2.5.2 LabCorp Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LabCorp SWOT Analysis
2.5.4 LabCorp Product and Services
2.5.5 LabCorp Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Color Genomics
2.6.1 Color Genomics Details
2.6.2 Color Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Color Genomics SWOT Analysis
2.6.4 Color Genomics Product and Services
2.6.5 Color Genomics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Illumina, Inc.
2.7.1 Illumina, Inc. Details
2.7.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Illumina, Inc. SWOT Analysis
2.7.4 Illumina, Inc. Product and Services
2.7.5 Illumina, Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Gene By Gene Ltd.
2.8.1 Gene By Gene Ltd. Details
2.8.2 Gene By Gene Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Gene By Gene Ltd. SWOT Analysis
2.8.4 Gene By Gene Ltd. Product and Services
2.8.5 Gene By Gene Ltd. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 23andMe Inc.
2.9.1 23andMe Inc. Details
2.9.2 23andMe Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 23andMe Inc. SWOT Analysis
2.9.4 23andMe Inc. Product and Services
2.9.5 23andMe Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad Laboratories SWOT Analysis
2.10.4 Bio-Rad Laboratories Product and Services
2.10.5 Bio-Rad Laboratories Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Agilent Technologies SWOT Analysis
2.11.4 Agilent Technologies Product and Services
2.11.5 Agilent Technologies Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Thermo Fisher Scientific
2.12.1 Thermo Fisher Scientific Details
2.12.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Thermo Fisher Scientific SWOT Analysis
2.12.4 Thermo Fisher Scientific Product and Services
2.12.5 Thermo Fisher Scientific Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Genomic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Genomic Testing Players Market Share
3.2.2 Top 10 Cancer Genomic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Genomic Testing Revenue and Market Share by Regions
4.2 North America Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
5 North America Cancer Genomic Testing Revenue by Countries
5.1 North America Cancer Genomic Testing Revenue by Countries (2015-2020)
5.2 USA Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
6 Europe Cancer Genomic Testing Revenue by Countries
6.1 Europe Cancer Genomic Testing Revenue by Countries (2015-2020)
6.2 Germany Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
6.4 France Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Genomic Testing Revenue by Countries
7.1 Asia-Pacific Cancer Genomic Testing Revenue by Countries (2015-2020)
7.2 China Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
7.5 India Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
8 South America Cancer Genomic Testing Revenue by Countries
8.1 South America Cancer Genomic Testing Revenue by Countries (2015-2020)
8.2 Brazil Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Genomic Testing by Countries
9.1 Middle East & Africa Cancer Genomic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Genomic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Genomic Testing Market Forecast by Type (2019-2024)
10.3 Breast Cancer Genomic Testing Revenue Growth Rate (2015-2025)
10.4 Lung Cancer Genomic Testing Revenue Growth Rate (2015-2025)
10.5 Blood Cancer Genomic Testing Revenue Growth Rate (2015-2025)
10.6 Liver Cancer Genomic Testing Revenue Growth Rate (2015-2025)
10.7 Stomach Cancer Genomic Testing Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Cancer Genomic Testing Market Segment by End Users
11.1 Global Cancer Genomic Testing Revenue Market Share by End Users (2015-2020)
11.2 Cancer Genomic Testing Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Diagnostic Laboratories Revenue Growth (2015-2020)
11.6 Academic and Research Institutes Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Cancer Genomic Testing Market Size Forecast (2021-2025)
12.1 Global Cancer Genomic Testing Market Size Forecast (2021-2025)
12.2 Global Cancer Genomic Testing Market Forecast by Regions (2021-2025)
12.3 North America Cancer Genomic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Genomic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Genomic Testing Revenue Market Forecast (2021-2025)
12.6 South America Cancer Genomic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Genomic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Genomic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Genomic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Genomic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Genomic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cancer Genomic Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Myriad Genetics Corporate Information, Location and Competitors
Table 7. Myriad Genetics Cancer Genomic Testing Major Business
Table 8. Myriad Genetics Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 9. Myriad Genetics SWOT Analysis
Table 10. Myriad Genetics Cancer Genomic Testing Product and Solutions
Table 11. Myriad Genetics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Positive Bioscience Corporate Information, Location and Competitors
Table 13. Positive Bioscience Cancer Genomic Testing Major Business
Table 14. Positive Bioscience Cancer Genomic Testing Total Revenue (USD Million) (2018-2019)
Table 15. Positive Bioscience SWOT Analysis
Table 16. Positive Bioscience Cancer Genomic Testing Product and Solutions
Table 17. Positive Bioscience Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Quest Diagnostics Corporate Information, Location and Competitors
Table 19. Quest Diagnostics Cancer Genomic Testing Major Business
Table 20. Quest Diagnostics Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 21. Quest Diagnostics SWOT Analysis
Table 22. Quest Diagnostics Cancer Genomic Testing Product and Solutions
Table 23. Quest Diagnostics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Centogene AG Corporate Information, Location and Competitors
Table 25. Centogene AG Cancer Genomic Testing Major Business
Table 26. Centogene AG Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 27. Centogene AG SWOT Analysis
Table 28. Centogene AG Cancer Genomic Testing Product and Solutions
Table 29. Centogene AG Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. LabCorp Corporate Information, Location and Competitors
Table 31. LabCorp Cancer Genomic Testing Major Business
Table 32. LabCorp Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 33. LabCorp SWOT Analysis
Table 34. LabCorp Cancer Genomic Testing Product and Solutions
Table 35. LabCorp Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Color Genomics Corporate Information, Location and Competitors
Table 37. Color Genomics Cancer Genomic Testing Major Business
Table 38. Color Genomics Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 39. Color Genomics SWOT Analysis
Table 40. Color Genomics Cancer Genomic Testing Product and Solutions
Table 41. Color Genomics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Illumina, Inc. Corporate Information, Location and Competitors
Table 43. Illumina, Inc. Cancer Genomic Testing Major Business
Table 44. Illumina, Inc. Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 45. Illumina, Inc. SWOT Analysis
Table 46. Illumina, Inc. Cancer Genomic Testing Product and Solutions
Table 47. Illumina, Inc. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Gene By Gene Ltd. Corporate Information, Location and Competitors
Table 49. Gene By Gene Ltd. Cancer Genomic Testing Major Business
Table 50. Gene By Gene Ltd. Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 51. Gene By Gene Ltd. SWOT Analysis
Table 52. Gene By Gene Ltd. Cancer Genomic Testing Product and Solutions
Table 53. Gene By Gene Ltd. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. 23andMe Inc. Corporate Information, Location and Competitors
Table 55. 23andMe Inc. Cancer Genomic Testing Major Business
Table 56. 23andMe Inc. Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 57. 23andMe Inc. SWOT Analysis
Table 58. 23andMe Inc. Cancer Genomic Testing Product and Solutions
Table 59. 23andMe Inc. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 61. Bio-Rad Laboratories Cancer Genomic Testing Major Business
Table 62. Bio-Rad Laboratories Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 63. Bio-Rad Laboratories SWOT Analysis
Table 64. Bio-Rad Laboratories Cancer Genomic Testing Product and Solutions
Table 65. Bio-Rad Laboratories Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Agilent Technologies Corporate Information, Location and Competitors
Table 67. Agilent Technologies Cancer Genomic Testing Major Business
Table 68. Agilent Technologies Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 69. Agilent Technologies SWOT Analysis
Table 70. Agilent Technologies Cancer Genomic Testing Product and Solutions
Table 71. Agilent Technologies Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 73. Thermo Fisher Scientific Cancer Genomic Testing Major Business
Table 74. Thermo Fisher Scientific Cancer Genomic Testing Total Revenue (USD Million) (2017-2018)
Table 75. Thermo Fisher Scientific SWOT Analysis
Table 76. Thermo Fisher Scientific Cancer Genomic Testing Product and Solutions
Table 77. Thermo Fisher Scientific Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Cancer Genomic Testing Revenue (Million USD) by Players (2015-2020)
Table 79. Global Cancer Genomic Testing Revenue Share by Players (2015-2020)
Table 80. Global Cancer Genomic Testing Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Cancer Genomic Testing Revenue Market Share by Regions (2015-2020)
Table 82. North America Cancer Genomic Testing Revenue by Countries (2015-2020)
Table 83. North America Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Table 84. Europe Cancer Genomic Testing Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Cancer Genomic Testing Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Cancer Genomic Testing Revenue by Countries (2015-2020)
Table 87. South America Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Cancer Genomic Testing Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Table 90. Global Cancer Genomic Testing Revenue (Million USD) by Type (2015-2020)
Table 91. Global Cancer Genomic Testing Revenue Share by Type (2015-2020)
Table 92. Global Cancer Genomic Testing Revenue Forecast by Type (2021-2025)
Table 93. Global Cancer Genomic Testing Revenue by Application (2015-2020)
Table 94. Global Cancer Genomic Testing Revenue Share by Application (2015-2020)
Table 95. Global Cancer Genomic Testing Revenue Forecast by Application (2021-2025)
Table 96. Global Cancer Genomic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Genomic Testing Picture
Figure 2. Global Cancer Genomic Testing Revenue Market Share by Type in 2019
Figure 3. Breast Cancer Genomic Testing Picture
Figure 4. Lung Cancer Genomic Testing Picture
Figure 5. Blood Cancer Genomic Testing Picture
Figure 6. Liver Cancer Genomic Testing Picture
Figure 7. Stomach Cancer Genomic Testing Picture
Figure 8. Others Picture
Figure 9. Cancer Genomic Testing Revenue Market Share by End Users in 2019
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Diagnostic Laboratories Picture
Figure 13. Academic and Research Institutes Picture
Figure 14. Others Picture
Figure 15. Global Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Cancer Genomic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Cancer Genomic Testing Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Cancer Genomic Testing Revenue Market Share in 2019
Figure 24. Global Top 10 Players Cancer Genomic Testing Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Cancer Genomic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Cancer Genomic Testing Revenue Market Share by Regions (2015-2020)
Figure 28. Global Cancer Genomic Testing Revenue Market Share by Regions in 2018
Figure 29. North America Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Europe Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 32. South America Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 34. North America Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Figure 35. North America Cancer Genomic Testing Revenue Market Share by Countries in 2019
Figure 36. USA Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 37. Canada Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 39. Europe Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Cancer Genomic Testing Revenue Market Share by Countries in 2019
Figure 41. Germany Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 42. UK Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 43. France Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 44. Russia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 45. Italy Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Cancer Genomic Testing Revenue Market Share by Countries in 2019
Figure 48. China Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Japan Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 50. Korea Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 51. India Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 53. South America Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Figure 54. South America Cancer Genomic Testing Revenue Market Share by Countries in 2019
Figure 55. Brazil Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Cancer Genomic Testing Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Cancer Genomic Testing Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 60. UAE Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Cancer Genomic Testing Revenue and Growth Rate (2015-2020)
Figure 63. Global Cancer Genomic Testing Revenue Share by Type (2015-2020)
Figure 64. Global Cancer Genomic Testing Revenue Share by Type in 2019
Figure 65. Global Cancer Genomic Testing Market Share Forecast by Type (2021-2025)
Figure 66. Global Breast Cancer Genomic Testing Revenue Growth Rate (2015-2020)
Figure 67. Global Lung Cancer Genomic Testing Revenue Growth Rate (2015-2020)
Figure 68. Global Blood Cancer Genomic Testing Revenue Growth Rate (2015-2020)
Figure 69. Global Liver Cancer Genomic Testing Revenue Growth Rate (2015-2020)
Figure 70. Global Stomach Cancer Genomic Testing Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Genomic Testing Revenue Share by Application (2015-2020)
Figure 73. Global Cancer Genomic Testing Revenue Share by Application in 2019
Figure 74. Global Cancer Genomic Testing Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 76. Global Clinics Revenue Growth Rate (2015-2020)
Figure 77. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 78. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Cancer Genomic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Cancer Genomic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Cancer Genomic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Cancer Genomic Testing Revenue Market Forecast (2021-2025)
Figure 84. Europe Cancer Genomic Testing Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Cancer Genomic Testing Revenue Market Forecast (2021-2025)
Figure 86. South America Cancer Genomic Testing Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Cancer Genomic Testing Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
がん検査/スクリーニングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Testing/Scree…- 子宮がん診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Uterine Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uterine Can…
- 乳癌リキッドバイオプシーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Breast Cancer Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer Liq…
- AFP検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global AFP Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AFP Testing market report provide…
- 前立腺がんスクリーニングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Cancer Scr…